REVIEWS |
|
M.Z. Ivanova (1), I.B. Zhurtova (2), S.Kh. Sizhazheva (2), A.M. Gubachikova (2)
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
|
10-15 |
|
|
M.B. Antsiferov (1), A.V. Zilov (2), O.M. Koteshkova (1), N.A. Demidov (3)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
|
16-23 |
ORIGINAL ARTICLES |
|
E.V. Pronin (1), M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
Rational pharmacotherapy of acromegaly: focus on treatment adherence
|
24-33 |
|
O.B. Glavnova (1), M.S. Shelygin (2), A.V. Salukhova (2)
Gestational diabetes mellitus: prevention of reproductive loss
|
34-37 |
|
D.I. Vasilevsky (1), S.G. Balandov (1), K.A. Anisimova (1), S.V. Tikhonov (2), V.D. Dekkanova (2)
Patient seeking bariatric care. Who is he?
|
38-44 |
|
M.A. Morzhanaeva (1), E.V. Svechnikova (1, 2)
Optimization of the diabetes screening questionnaire for patients with psoriasis
|
45-50 |
|
N.A. Shevkunova (1), M.V. Vorobyov (2), V.V. Gushchin (2)
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
|
51-54 |
|
T.A. Zelenina (1), V.V. Salukhov (1), A.B. Zemlyanoy (2), O.E. Chebykina (3)
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
|
55-60 |
|
Zh.V. Paltsman, L.I. Velikanova, N.V. Vorokhobina, S.B. Shustov, Z.R. Shafigullina, A.A. Lisitsyn, E.V. Malevanaya, E.G. Strelnikova
Features of steroid metabolomics in patients with Cushing's syndrome with unilateral and bilateral adrenocortical pathology
|
62-68 |
|
|
A.E. Bagriy (1), E.V. Shchukina (1), V.A. Efremenko (1), E.S. Mikhailichenko (1), E.V. Suprun (2)
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
|
69-75 |
|
N.A. Demidov
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
|
76-83 |
|
T.A. Ilyinskaya, V.P. Kitsyshin, V.V. Salukhov
Influence of impaired regulation of carbohydrate metabolism on circadian glycemic variability and its role in the development of cardiovascular complications in patients with type 2 diabetes mellitus
|
84-89 |
|
D.V. Rebrova (1), V.F. Rusakov (1), E.A. Fedorov (1), L.M. Krasnov (1), N.V. Vorokhobina (2), Sh.Sh. Shikhmagomedov (1), S.L. Vorobyev (3), I.V. Sleptsov (1), R.A. Chernikov (1), T.V. Savelyeva (1), A.A. Semenov (1), I.K. Chinchuk (1), I.V. Sablin (1), T.S. Pridvizhkina (1), Yu.N. Fedotov (1)
Rare case of pheochromocytoma with calcitonin hypersecretion
|
90-98 |
|
I.A. Barsukov, A.A. Demina
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
|
99-104 |
|
I.B. Zhurtova, M.A. Elgarova, L.A. Anaeva, A.Z. Getigezheva
Familial isolated pituitary adenomas (FIPA): a clinical case of prolactinoma in the same family
|
105-109 |
|
E.Yu. Smirnova
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
|
110-115 |
|
N.I. Volkova, L.A. Ganenko, L.V. Sarkisyan
Hypoglycemic syndrome: justification for standardized diagnostic approach
|
116-119 |
|
N.A. Chernikova, O.A. Knyshenko, L.P. Ivanova
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
|
120-122 |
Русский
